ProShares - UltraShort Nasdaq Biotechnology (BIS) ETF Holdings & Analysis
ETFOther
What BIS does
The ProShares UltraShort Nasdaq Biotechnology fund is engineered to achieve daily returns that are precisely two times the inverse (-2x) of the Nasdaq Biotechnology Index's daily performance. This objective is measured before accounting for any associated fees and operational expenses.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| Net Other Assets (Liabilities) | 100.00% | |
| NASDAQ Biotechnology Index SWAP Bank of America NA | 0.00% | |
| NASDAQ Biotechnology Index SWAP Societe Generale | 0.00% | |
| NASDAQ Biotechnology Index SWAP Citibank NA | 0.00% | |
| NASDAQ Bio Index SWAP BNP Paribas | 0.00% | |
| NASDAQ Biotechnology Index SWAP UBS AG | 0.00% |
Sector allocation
| Cash & Others | 100.00% |
Geographic allocation
| Other | 100.00% |
PortView Portfolio Insights
PortView analyzes how BIS fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze BIS in PortView →Related securities
Related stocks
Frequently asked questions
- What does BIS track?
- BIS is the ProShares - UltraShort Nasdaq Biotechnology, a Other ETF.
- What is the expense ratio of BIS?
- Expense ratio data for BIS is shown on the page when available from our data provider.
- What are the largest holdings in BIS?
- Top holdings include Net Other Assets (Liabilities), NASDAQ Biotechnology Index SWAP Bank of America NA, NASDAQ Biotechnology Index SWAP Societe Generale, NASDAQ Biotechnology Index SWAP Citibank NA, NASDAQ Bio Index SWAP BNP Paribas.
- How can PortView analyze BIS overlap with other ETFs?
- PortView computes the holdings overlap between BIS and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.